Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.24 EUR | +1.95% | +3.67% | +38.51% |
Sep. 17 | PHILIPS NV : JP Morgan reaffirms its Neutral rating | ZD |
Sep. 17 | Royal Philips' Enhanced Endovascular Navigation Tool Gets US Regulator's Approval | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
27.74 | +0.15% | 17 | |||||||
642.56 | +4.63% | 25 | |||||||
288.05 | +4.35% | 22 | |||||||
483.95 | -1.51% | 26 | |||||||
87.26 | +4.49% | 32 | |||||||
59.36 | +20.14% | 19 | |||||||
79.42 | +14.50% | 27 | |||||||
147.51 | +6.65% | 17 | |||||||
94.96 | +9.61% | 18 | |||||||
365.90 | +57.94% | 20 | |||||||
232.48 | -7.66% | 9 | |||||||
2,838.57 | +12.44% | 14 | |||||||
148.79 | +14.88% | 23 | |||||||
340.22 | +3.52% | 17 | |||||||
87.33 | +5.60% | 15 | |||||||
133.87 | +9.01% | 18 | |||||||
79.74 | +22.15% | 11 | |||||||
- | - | 7.850 | -41.33% | 3 | |||||
70.00 | +22.81% | 15 | |||||||
179.63 | +18.79% | 8 | |||||||
Average | 319.76 | +9.06% | 18 | ||||||
Weighted average by Cap. | 366.38 | +6.85% | 23 |
- Stock Market
- Equities
- PHIA Stock
- Sector Philips NV
- Sector consensus